surmount-1 tirzepatide non-diabetic obesity weight loss Trial Tirzepatide for the Maintenance of

An open-label introductory period of the first 36 weeks, during which all subjects were treated with tirzepatide, followed by a 52-week double-blind treatment period, during which subjects were randomly assigned to receive either tirzepatide or placebo

That same 20 units at 10 mg/mL would only deliver 2 mg

Busetto noted

Step 1: Rule out the obvious

What happens if you draw too much A single accidental overdose of tirzepatide is unlikely to cause serious harm in most healthy individuals, but it will amplify side effects

Stop using Zepbound and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting